ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

New Chemotherapy, Other Modality Progress Described

March 30, 1979

In Brief

February 7, 2014

Iressa May Benefit Some Breast Cancer, Studies Find

December 27, 2002

CHOP Evolution Remains Touchy Issues; Contractors Say NCI Plan Too Burdensome

April 22, 1983

In Brief: Sartorelli Replaces Cole As Director Of Yale Comprehensive Center; NSABP Ends Segmental Trials

March 2, 1984

DCT T Consider Reissuing RFA For Surgical Oncology

March 4, 1983